Fellows' Journal Club

2018-2019 Academic Year

Date Speaker Title Download
Nov 13, 2018 Lauren Shea Lymphoma
Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety
Dec 11, 2018 Amber Xu Breast Cancer
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Jan 10, 2019 Mary-Kate Malecek Lower GI
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Bruna Pellini Ferreira Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101 PubMed
Feb 13, 2019 Ramzi Abboud Upper GI
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study
Ramon Jin Trifluridine/Tipiracil Versus Placebo in Patients With Heavily Pretreated Metastatic Gastric Cancer (TAGS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial PubMed
Feb 14, 2019 Vanessa Eulo MPN
A Phase 2 Study of Ruxolitinib in Combination With Azacitidine in Patients With Myelofibrosis
Ryan Day Momelotinib Versus Best Available Therapy in Patients With Myelofibrosis Previously Treated With Ruxolitinib (SIMPLIFY 2): A Randomised, Open-Label, Phase 3 Trial PubMed
Mar 20, 2019 Aabha Oza Lung
Pembrolizumab Plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
Patrick Grierson Pembrolizumab Plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer PubMed
Apr 18, 2019 Daniel Guy Heme
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Amber Afzal Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer PubMed
Apr 25, 2019 Scott Goldsmith Genitourinary
Pembrolizumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma
May 23, 2019 Nkiruka Ezenwajiaku Melanoma
Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF-Mutant Melanoma (COLUMBUS): A Multicentre, Open-Label, Randomised Phase 3 Trial
Gradon Nielsen Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain PubMed
Jun 13, 2019 Brett Herzog Primary Gliomas
Neoadjuvant Anti-PD-1 Immunotherapy Promotes a Survival Benefit With Intratumoral and Systemic Immune Responses in Recurrent Glioblastoma